Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Update

Idorsia Ltd (OTCMKTS:IDRSF) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 9,037,200 shares, a growth of 17.5% from the November 15th total of 7,692,300 shares. Based on an average daily trading volume, of 3,000 shares, the short-interest ratio is currently 3,012.4 days.

Idorsia Price Performance

Idorsia stock remained flat at $1.50 during mid-day trading on Monday. 523 shares of the company’s stock traded hands, compared to its average volume of 3,256. The business has a 50-day moving average of $1.41 and a two-hundred day moving average of $2.10. Idorsia has a one year low of $0.81 and a one year high of $2.88.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.